SECOND AMENDMENT TO CREDIT AGREEMENTCredit Agreement • March 16th, 2012 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • New York
This Second Amendment to Credit Agreement (defined below), dated as of March 12, 2012 (this “Agreement”), is entered into by and among Angiotech Pharmaceuticals, Inc., a corporation organized under the laws of the Province of British Columbia, Canada (“Parent”), each of Parent’s Subsidiaries listed as a “Borrower” on the signature pages hereto (each a “Borrower” and collectively, the “Borrowers”), Wells Fargo Capital Finance, LLC, a Delaware limited liability company (“WFCF”), as arranger and administrative agent for the Lenders (in such capacity, together with its successors and assigns in such capacity, the “Agent”), and the lenders named on the signature pages hereto (the “Lenders”).
